Antibody-Mediated Rejection of the Kidney after Simultaneous Pancreas-Kidney Transplantation

The prevalence, risk factors, and outcome of antibody-mediated rejection (AMR) of the kidney after simultaneous pancreas-kidney transplantation are unknown. In 136 simultaneous pancreas-kidney recipients who were followed for an average of 3.1 yr, 21 episodes of AMR of the kidney allograft were iden...

Full description

Saved in:
Bibliographic Details
Published in:Journal of the American Society of Nephrology 2008-04, Vol.19 (4), p.812-824
Main Authors: PASCUAL, Julio, SAMANIEGO, Milagros D, PIRSCH, John D, TORREALBA, José R, ODORICO, Jon S, DJAMALI, Arjang, BECKER, Yolanda T, VOSS, Barbara, LEVERSON, Glen E, KNECHTLE, Stuart J, SOLLINGER, Hans W
Format: Article
Language:English
Subjects:
Adult
Antibodies - immunology
Biological and medical sciences
Clinical Research
Female
Follow-Up Studies
Graft Rejection - epidemiology
Graft Rejection - immunology
Humans
Kidney Transplantation - immunology
Kidney Transplantation - methods
Male
Medical sciences
Nephrology. Urinary tract diseases
Pancreas Transplantation - methods
Citations: Items that cite this one
Online Access:Get full text
Tags: Add Tag
No Tags, Be the first to tag this record!
Description
Summary:The prevalence, risk factors, and outcome of antibody-mediated rejection (AMR) of the kidney after simultaneous pancreas-kidney transplantation are unknown. In 136 simultaneous pancreas-kidney recipients who were followed for an average of 3.1 yr, 21 episodes of AMR of the kidney allograft were identified. Eight episodes occurred early (
ISSN:1046-6673
1533-3450
DOI:10.1681/ASN.2007070736